Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Minutes after the Centers for Disease Control and Prevention (CDC) issued its new guidance Thursday that those fully vaccinated against COVID-19 can now (mostly) ditch their masks both indoors and out, Twitter and other social media lit up with reaction. Some
0 Comments
INO-4800 was shown to be safe, well-tolerated and immunogenic in all age groups Phase 2 results informed INOVIO’s selection of 2.0 mg dose for the Phase 3 segment of the trial Data published as a preprint in MedRxiv PLYMOUTH MEETING, Pa., May 10, 2021 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to
0 Comments
FDA Approves Zynrelef (bupivacaine and meloxicam) for the Management of Postoperative Pain SAN DIEGO, May 13, 2021 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the U.S. Food
0 Comments
In this article HSEP-GB HSEF-GB An ambulance arrives at the A and E department of the Mater Misericordiae University Hospital in Dublin on Monday, 18 January, 2021. Artur Widak | NurPhoto via Getty Images LONDON — Ireland’s health service shut down its computer systems on Friday after being hit with a “sophisticated” ransomware attack. The
0 Comments
There is no long-term benefit to surgically placing tympanostomy tubes in a young child’s ears to reduce the rate of recurrent ear infections during the ensuing two years compared with giving oral antibiotics to treat ear infections, a randomized trial led by UPMC Children’s Hospital of Pittsburgh and University of Pittsburgh pediatrician-scientists determined. The trial
0 Comments
Inpatient consults for alcohol-related GI and liver diseases surged after the beginning of the COVID-19 pandemic in 2020 and remained elevated, researchers found. The proportion of inpatients requiring endoscopic interventions for their alcohol-related GI and liver diseases also increased, suggesting a worsening trend in severity, according to data presented at a pre-meeting press conference for
0 Comments
A new analysis, published in Academic Radiology, suggests that almost a quarter of interval breast cancers could have been caught earlier than they were. The term “interval breast cancer” refers to cancers that present themselves or are detected within about 12 months after a mammogram that came back normal. They are considered “interval” cancers because
0 Comments
Stress, anxiety, and depression threatened to destroy Johnathan’s 15-year teaching career. But a simple change in mindset enabled him to rekindle the love affair with his chosen profession The last day of the spring term in school is normally joyous. January and February are tough going, so Easter is a time for everyone to give
0 Comments
Several years ago, as some US emergency departments (EDs) prepared to implement the recently approved high-sensitivity assay for cardiac troponins, there was still apprehension about broadly applying the exquisitely sensitive test to the mass of patients who would present with chest discomfort. Would the assay’s prowess in detecting myocardial damage, whether or not from acute
0 Comments
How can we use the night sky to be more present? When it comes to calming down and easing anxiety, a tip I share regularly is to go outside and look up. When I see the bright blue sky and fluffy white clouds, I’m reminded that I’m a tiny speck on a blue marble in
0 Comments
A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what’s anticipated to be the second line of defence against the virus. Professor John Hayball is a researcher at the University of South Australia and Chief Scientific Officer at Adelaide biotechnology
0 Comments
A first-in-class drug under development for severe asthma passed what its developers hope is the final test: achieving its primary endpoint in a phase III registration trial dubbed NAVIGATOR and now reported in a major journal. Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin (TSLP), cut the annualized rate of asthma exacerbations by more than
0 Comments
by Ashley Drake BSN, RN March 11, 2020. No longer a placeholder on the calendar, but rather an inflection point in life as we knew it. Nurses around the world have undoubtedly played an intimate, yet integral role in this monumental event, the COVID 19 global pandemic. A threat was introduced and all eyes were
0 Comments
Five cosy games to chill out with in 2021 Traditionally rooted in competitive player-vs-player or player-vs-computer design, video games are broadening their horizons. A rise in relaxing, uncompetitive games is bringing about new ways to enjoy playing, and they’re perfect for people looking for a break from the pressure that gaming (and life!) often demands.
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The Centers for Disease Control and Prevention’s (CDC) Director Rochelle Walensky, MD, signed off on an advisory panel’s recommendation today endorsing the use of the Pfizer-BioNTech COVID-19 vaccine in adolescents ages 12 to 15. Earlier in the afternoon the CDC’s Advisory
0 Comments
“The effort from the start was to save lives of women with ovarian cancer. To build evidence for a screening programme that the NHS could introduce. To have an impact on the lives of thousands of women who are affected by ovarian cancer each year.” Professor Usha Menon, a gynaecologist at University College London, has
0 Comments
Finerenone, an investigational agent from a new drug class, just scored a second pivotal-trial win after showing significant benefit for slowing progression of diabetic kidney disease in patients with type 2 diabetes in the FIDELIO-DKD pivotal trial with more than 5700 patients. Top-line results from FIGARO-DKD showed significant benefit for the primary endpoint of cardiovascular
0 Comments